Damon Wayans uses comedy for Genentech DME awareness campaign
The comedian and type 2 diabetic is partnering with Genentech to spotlight diabetic macular edema through humor and personal experience.
Damon Wayans is bringing his comedic background to a new health awareness effort. The actor and comedian has teamed up with Genentech on the "All Eyes on DME" campaign, which focuses on diabetic macular edema, a vision-threatening complication of diabetes. Wayans, who lives with type 2 diabetes, discussed the partnership and his advocacy in a recent interview with Fierce Pharma.
Wayans said he leans on humor and relatability to make a serious subject more approachable. He also emphasized the importance of authenticity, noting that audiences respond to sincerity in health messaging. His own experience as a diabetic shapes how he talks about the risks to sight and the need for awareness.
The campaign pairs a familiar comedic voice with a clinical topic that many people with diabetes may not fully understand. By using Wayans's personal story and tone, Genentech aims to encourage more conversation about DME and the importance of eye health among those living with diabetes.
More in Medicine & Biotech
Ebola Vaccine Trial Launches in DR Congo Outbreak Zone
Health workers in DR Congo have begun testing whether a vaccine designed for a different Ebola strain can protect against the current outbreak.
Beacon Gene Therapy for Rare Vision Loss Succeeds in Pivotal Trial
A pivotal trial of Beacon Therapeutics' gene therapy for X-linked retinitis pigmentosa improved visual acuity, clearing the path toward an FDA submission.
Alkermes orexin agonist shows early promise for ADHD
Early-stage data suggest Alkermes' orexin agonist could expand the drug class beyond sleep disorders into ADHD.
Telix to Buy ITM for $1.65B, Challenging Novartis in Radiopharma
The acquisition gives Telix a late-stage pipeline and supply network that could compete with Novartis' Lutathera.